Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vital Needs International (VNI) is a medical technology company dedicated to developing innovative and accessible respiratory care solutions. The company's flagship product, the VNI-100, is a non-invasive ventilation (NIV) device designed to provide high-quality respiratory support in both clinical and home settings. Originally developed to address the global shortage of ventilators during the COVID-19 pandemic, the VNI-100 emphasizes portability, ease of use, and cost-effectiveness. VNI focuses on expanding access to critical care technology, particularly in underserved markets and resource-limited environments. Their products are engineered to provide continuous positive airway pressure (CPAP) and bilevel support for patients experiencing respiratory distress.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vital Needs International.